SynsoryBio
Site unreachable"If-then" conditional logic for protein drugs
What it does
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
Next to it in Healthcare and bio · Conditional protein therapeutics
- Origami Therapeutics, Inc.Y Combinator W22
Oral drugs to halt neurodegeneration
- Eris BiotechY Combinator W24
Our drugs engage the immune system to fight tumors
- Catena BiosciencesY Combinator S21
Using protein coupling to build new therapies
- FREZENT Biological SolutionsSOSV SOSV IndieBio NY 07
Changing the prognosis for patients with advanced stage cancer
- Palate TherapeuticsSOSV SOSV IndieBio NY 06
Unlock the Taste of Health
- Scioto BiosciencesPlug and Play PnP 2025
Scioto is a preclinical stage company developing innovative therapies devoted to having a transformative impact.
- FinalDoseY Combinator X26
Programmable DNA drug destroying all cancers, unlocking 80% of targets
- EpinomaY Combinator S21
We engineer proteins that control the operating system of biology.